Skip to content
SentinelMarket desk
Switch to dark mode

바이오니아

064550KOSDAQView the 제약 sectorTheme Bio & healthcare

7,760KRWMarket close of 10/20 (Tue)

Down -3.12%-250KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)7,770KRWUp +0.13%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
7,940
High
8,140
Low
7,700
Day range
Day range low 7,700 high 8,140, open 7,940, close 7,760, previous close 8,010
Volume
8×10K shares
656.10 million KRW 0.30× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 5,790 to 15,500 won, 20% up from the low

20% of the way up from the lowest close in 1 year (252 sessions) · -49.9% from the high

Usual range

Nothing unusual in the 4 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
  • Daily moveusual range-3.12%-3.12%, 1.1× the usual (20-session average ±2.80%)
    That day -3.12% · usual ±2.80% · large-move threshold ±5.6%

The other 3 are within the usual range

  • Trading value0.3×usual range
  • EarningsOperating income, 8 quartersOperating income, 8 quarters
  • Data date10/20 (Tue)Market close
See the full check report

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue81.8B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +10.7%
    vs. prior quarter
    +2.5%
  • Operating income-525.72 million KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Turned to loss
    vs. prior quarter
    Turned to loss
  • Operating margin-0.6%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -6.5 pp
    vs. prior quarter
    -4.0 pp

Quarterly operating income trend

As of the latest official close · 2026-10-20Valuation filing date · 2026-05-15
2021Q1 18.1B KRW2026Q1 -525.72 million KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Down -1.68%

· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
셀트리온Close over the last 20 sessions +11.4%Down -0.40%139.2B KRW
삼성바이오로직스Close over the last 20 sessions -1.3%Down -2.52%129.9B KRW
삼익제약Close over the last 20 sessions -20.4%Up +2.77%76.0B KRW
녹십자엠에스Close over the last 20 sessions +30.5%Up +6.67%55.6B KRW
유한양행Close over the last 20 sessions +11.5%Down -1.37%41.6B KRW

Schedule

  • Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.